1. Home
  2. BWMN vs PRME Comparison

BWMN vs PRME Comparison

Compare BWMN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowman Consulting Group Ltd.

BWMN

Bowman Consulting Group Ltd.

HOLD

Current Price

$26.10

Market Cap

508.6M

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.08

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWMN
PRME
Founded
1995
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
508.6M
536.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
BWMN
PRME
Price
$26.10
$3.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$45.50
$7.56
AVG Volume (30 Days)
129.2K
4.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
329.41
18.18
EPS
N/A
N/A
Revenue
$490,017,000.00
$4,632,000.00
Revenue This Year
$14.93
$7.06
Revenue Next Year
$11.57
$47.01
P/E Ratio
N/A
N/A
Revenue Growth
14.88
55.28
52 Week Low
$25.07
$2.67
52 Week High
$45.83
$6.94

Technical Indicators

Market Signals
Indicator
BWMN
PRME
Relative Strength Index (RSI) 31.75 42.35
Support Level $25.52 $2.68
Resistance Level $36.86 $3.68
Average True Range (ATR) 1.12 0.26
MACD 0.00 -0.09
Stochastic Oscillator 20.81 10.18

Price Performance

Historical Comparison
BWMN
PRME

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: